ArticleIBRO neuroscience reports2025
Prospero-related homeobox protein 1 (Prox1) enhances myelin sheath regeneration in injured sciatic nerve.
Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peripheral nerve injury (PNI), such as sciatic nerve injury (SNI), often results in poor functional recovery due to myelin damage, which critically impairs nerve regeneration. Prox1, a homeobox transcription factor known to influence neurogenesis, has not been studied in peripheral myelin regeneration. Objective: To investigate morphological changes in myelin sheaths and the expression of Prox1 and MBP proteins during sciatic nerve repair, and to determine the role of Prox1 in nerve regeneration. Methods: Mice were divided into seven groups (n = 8): one control and six experimental groups based on sciatic nerve collection at Days 3, 4, 5, 6, 7, and 14 post-injury. H&E staining, electron microscopy, Luxol Fast Blue staining, Western Blot, and immunohistochemistry were used to assess myelin morphology and Prox1/MBP expression. Immunofluorescence analyzed colocalization of Prox1 and MBP. Prox1 was overexpressed in Schwann cells via plasmid transfection, and MBP levels were measured by Western blot. Results: Control group myelin sheaths showed normal structure, while Day 7 nerves displayed disorganized sheaths with vacuolation and axonal spacing. By Day 14, myelin structure largely recovered. MBP levels decreased from Day 3, reached a minimum at Day 7, and increased significantly by Day 14. Prox1 expression rose on Day 3, peaked on Day 7, and declined by Day 14. Prox1 and MBP colocalized in injured nerves, and Prox1 overexpression significantly increased MBP levels in Schwann cells. Conclusion: Prox1 protein level is upregulated in injured sciatic nerve, and Prox1 overexpression promotes the increase of MBP protein level, which positively correlates to myelin regeneration in morphology. This strongly suggests that Prox1 promotes myelin regeneration of injured peripheral nerves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.